SLC25A46 as a Novel Mitochondrial Regulator and Biomarker in Breast Cancer

Explore groundbreaking research on triple-negative breast cancer in this 56-minute webinar featuring Dr. Heather K. Beasley, a postdoctoral research scholar at Vanderbilt University. Delve into the role of SLC25A46, a novel mitochondrial protein, as a potential biomarker and regulator in breast cancer. Learn about the application of PrediXcan, a gene-based statistical algorithm, to analyze genetically predicted gene expression in diverse patient populations. Discover how ancestry influences breast cancer etiology and prognosis, with a focus on African American and Latina women. Gain insights into metabolic reprogramming of cancer cells and its impact on treatment responses. Understand the significance of SLC25A46 expression differences among women of various African ancestries and its implications for cancer outcomes. Enhance your knowledge of cutting-edge breast cancer research and its potential for improving diagnosis and treatment strategies.